Skip to main content
Market intelligence
MLTXHealthcare

MoonLake Immunotherapeutics insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 22, 2026Matthias BodenstedtChief Financial OfficerSale39,120$22.04$862,205
Jun 18, 2026Matthias BodenstedtChief Financial OfficerSale17,876$19.67$351,576
Jun 17, 2026Kristian ReichChief Scientific OfficerSale150,000$19.01$2,851,005